ArticleJournal of thoracic disease2025
Efficacy and safety of intercostal nerve block for postoperative analgesia in patients with stage III tuberculous empyema: a retrospective study based on propensity score matching.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stage III tuberculous empyema causes irreversible thoracic pathologies and secondary deformities, with traditional thoracotomy/video-assisted thoracoscopic surgery (VATS) as main treatments. However, its postoperative pain is severe (due to extensive tissue damage) and understudied-existing analgesic research for this population is scarce and biased, while unmanaged pain worsens patient quality of life. This study aimed to evaluate the efficacy of intercostal nerve block (INB) combined with patient-controlled intravenous analgesia (PCIA) for postoperative pain management in patients with stage III tuberculous empyema. Methods: Clinical data of 315 patients with tuberculous empyema admitted to Xi'an Chest Hospital from August 9, 2020 to March 25, 2025 were retrospectively analyzed. Patients were divided into group A (n=54, INB + PCIA + oral medications) and group B (n=261, PCIA + oral medications). General clinical data, postoperative Numerical Rating Scale (NRS) scores, frequency of rescue analgesia, postoperative tube indwelling time, drainage volume, and hospitalization costs were compared between groups. Propensity score matching (PSM) was performed to control for confounding factors. Statistical analyses included the t-test, Chi-squared test, rank sum test, etc., and sensitivity analysis was conducted by excluding data from the first two years. Results: The 24-hour postoperative NRS score was 2.00 (2.00, 3.00) in group A Conclusions: In patients with stage III tuberculous empyema, INB administered before chest closure combined with PCIA and oral medications enhances postoperative analgesic efficacy and reduces the need for rescue analgesia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.